Re: What 's the rush Robry
>> There is a lot of variance in the human genome. A lot of varience in the
>> human immune system. There are all sorts of unexpected side effects in
>> medicine. Allergic reactions, ananphylactic reactions, antagonist reactions,
>> agonistic reactions, paradoxical reactions even after all the testing and
>> reviewing no telling what this vaccine will do.
For something less lethal, certainly, but with COVID-19 there are strong
correlations between deaths and confirmed cases (lagged appropriately), strong
correlations between confirmed cases and degree-days (lagged appropriately),
a global history of wintertime mortality hitting 10% peaks by such measures,
and a global mortality rate that is now in an accelerating climb in parallel
with climate in the Northern Hemisphere.
While there is a downside to rushing, there is a downside to waiting that in
my opinion is huge. The only question is which risk is larger. I cannot
answer that question because I only have sufficient data to measure risk on
that "waiting" side. I do not have the capability to measure the "rush" side.
I will say that in injectables, there are injectable chemicals, and there are
injectable biologicals. I have seen documentation on the chemical side, but
I have yet to find any good articles on adverse reactions to injectable
biologicals, other than manufacturing deficiencies which are unrelated to
the injectable but rather the manufacturing and/or distribution sequence.
But does it have to be "all or nothing"? How about an intermediate step while
we wait for the bureaucrats to think it all over... Say authorizing a million
dose maximum for the most at risk... The elderly... older front-line-medical...
and so forth.
Making the gravely-at-risk wait in their volnerability while the national
stockpiles grow (yes the US has taken delivery already of millions of doses)
I see as unconscionable.